Showing results (151-160 of 255) with videos related to
Sort By:
Pageof 26
JACC. Basic to Translational Science|May 28, 2025
Derisking Phase II Clinical Trials in Heart Failure: A Position Paper from JACC: Basic to Translational Science and the Heart Failure CollaboratoryDouglas L Mann, G Michael Felker, Ellis F Unger, et al.Nature Genetics|October 17, 2006
Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)Christopher R Ingraham, Akira Kinoshita, Shinji Kondo, et al.The Journal of Physiology|June 28, 2019
Fast skeletal muscle troponin activator CK-2066260 increases fatigue resistance by reducing the energetic cost of muscle contractionArthur J Cheng, Darren T Hwee, Leo H Kim, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 5, 2021
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of <i>reldesemtiv</i> in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trialStacy A Rudnicki, Jinsy A Andrews, Angela Genge, et al.Muscle & Nerve|March 18, 2014
Tirasemtiv amplifies skeletal muscle response to nerve activation in humansRichard Hansen, Khalil G Saikali, Willis Chou, et al.JACC. Heart Failure|February 10, 2020
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HFJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.The Journal of General Physiology|February 20, 2024
Tirasemtiv enhances submaximal muscle tension in an Acta1:p.Asp286Gly mouse model of nemaline myopathyRicardo A Galli, Tamara C Borsboom, Charlotte Gineste, et al.Journal of Medical Genetics|April 11, 2013
Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutationsJosine Marieke de Winter, Danielle Buck, Carlos Hidalgo, et al.Journal of Medicinal Chemistry|March 7, 2024
Cardiac Troponin Activator <b>CK-963</b> Increases Cardiac Contractility in RatsScott E Collibee, Antonio Romero, Alexander R Muci, et al.JACC. Heart Failure|December 3, 2014
Safety and tolerability of omecamtiv mecarbil during exercise in patients with ischemic cardiomyopathy and anginaBarry H Greenberg, Willis Chou, Khalil G Saikali, et al.Pageof 26